Cargando…

Inhibition of the amino‐acid transporter LAT1 demonstrates anti‐neoplastic activity in medulloblastoma

Most cases of medulloblastoma (MB) occur in young children. While the overall survival rate can be relatively high, current treatments combining surgery, chemo‐ and radiotherapy are very destructive for patient development and quality of life. Moreover, aggressive forms and recurrences of MB cannot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cormerais, Yann, Pagnuzzi‐Boncompagni, Marina, Schrötter, Sandra, Giuliano, Sandy, Tambutté, Eric, Endou, Hitoshi, Wempe, Michael F., Pagès, Gilles, Pouysségur, Jacques, Picco, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433660/ https://www.ncbi.nlm.nih.gov/pubmed/30784173 http://dx.doi.org/10.1111/jcmm.14176

Ejemplares similares

The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
por: Cormerais, Yann, et al.
Publicado: (2018)

Inhibiting ALK2/ALK3 Signaling to Differentiate and Chemo-Sensitize Medulloblastoma
por: Filipponi, Doria, et al.
Publicado: (2022)

Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma
por: Pagnuzzi-Boncompagni, Marina, et al.
Publicado: (2021)

Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas
por: Penco-Campillo, Manon, et al.
Publicado: (2022)

The Central Role of Amino Acids in Cancer Redox Homeostasis: Vulnerability Points of the Cancer Redox Code
por: Vučetić, Milica, et al.
Publicado: (2017)

Amino Acid Transporters Are a Vital Focal Point in the Control of mTORC1 Signaling and Cancer
por: Cormerais, Yann, et al.
Publicado: (2020)

Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor
por: Okanishi, Hiroki, et al.
Publicado: (2020)

A Cystine-Cysteine Intercellular Shuttle Prevents Ferroptosis in xCT(KO) Pancreatic Ductal Adenocarcinoma Cells
por: Meira, Willian, et al.
Publicado: (2021)

Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2022)

The c-Jun N-terminal kinase prevents oxidative stress induced by UV and thermal stresses in corals and human cells
por: Courtial, Lucile, et al.
Publicado: (2017)

VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
por: Penco-Campillo, Manon, et al.
Publicado: (2020)

Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2023)

Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models
por: Shi, Zitong, et al.
Publicado: (2023)

Genetic disruption of the pH(i)-regulating proteins Na(+)/H(+) exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells
por: Parks, Scott K., et al.
Publicado: (2016)

Author Correction: VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
por: Penco-Campillo, Manon, et al.
Publicado: (2020)

Knockout of LATS1 induces neoplastic phenotype in hepatic oval cells
por: Sun, Qigang, et al.
Publicado: (2020)

Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation
por: Quan, Lili, et al.
Publicado: (2020)

JPH203, a selective L-type amino acid transporter 1 inhibitor, induces mitochondria-dependent apoptosis in Saos2 human osteosarcoma cells
por: Choi, Dae Woo, et al.
Publicado: (2017)

Structural and functional analysis of coral Hypoxia Inducible Factor
por: Zoccola, Didier, et al.
Publicado: (2017)

Angiogenesis and Lymphangiogenesis in Medulloblastoma Development
por: Penco-Campillo, Manon, et al.
Publicado: (2023)

Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells
por: Cai, Linzhi, et al.
Publicado: (2020)

AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity
por: Brolih, Sanja, et al.
Publicado: (2018)

Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno‐foetal amino acid transport
por: Zaugg, Jonas, et al.
Publicado: (2020)

MON-470 Pharmacological Inhibition of LAT1 Suppresses Proliferation and Hormone Synthesis in Rat Pituitary Tumor GH4 Cells [cc1] Synthesis May Be Better as Only mRNAs Were Measured
por: Sato, Motoyasu, et al.
Publicado: (2019)

Phosphoproteomics revealed cellular signals immediately responding to disruption of cancer amino acid homeostasis induced by inhibition of l-type amino acid transporter 1
por: Okanishi, Hiroki, et al.
Publicado: (2022)

Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors
por: Barollo, Susi, et al.
Publicado: (2016)

Dysfunctional LAT2 Amino Acid Transporter Is Associated With Cataract in Mouse and Humans
por: Knöpfel, Emilia Boiadjieva, et al.
Publicado: (2019)

The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer
por: Häfliger, Pascal, et al.
Publicado: (2019)

The L-type Amino Acid Transporter (LAT1) Expression in Patients with Scoliosis
por: Demura, Satoru, et al.
Publicado: (2021)

Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5
por: Giuliano, Sandy, et al.
Publicado: (2019)

Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma
por: Vaillant, Catherine, et al.
Publicado: (2015)

l-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia
por: Huttunen, Johanna, et al.
Publicado: (2019)

The Regulation and Function of the L-Type Amino Acid Transporter 1 (LAT1) in Cancer
por: Salisbury, Travis B, et al.
Publicado: (2018)

Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and ‐LAT2, and LAT1 and LAT2 Substrates and Inhibitors
por: Kantipudi, Satish, et al.
Publicado: (2021)

MBRS-46. CHARTING NEOPLASTIC AND IMMUNE CELL HETEROGENEITY IN HUMAN AND GEM MODELS OF MEDULLOBLASTOMA USING scRNAseq
por: Donson, Andrew, et al.
Publicado: (2020)

Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma
por: Dumond, Aurore, et al.
Publicado: (2021)

Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation
por: Najafi, Maryam, et al.
Publicado: (2016)

BIMG-18. ELEVATED CYSTATHIONINE IN MEDULLOBLASTOMA DEMONSTRATES TUMOR-SPECIFIC METHIONINE METABOLISM
por: Tikunov, Andrey, et al.
Publicado: (2021)

Ubiquitylation and endocytosis of the human LAT1/SLC7A5 amino acid transporter
por: Barthelemy, Céline, et al.
Publicado: (2019)

Choroid plexus LAT2 and SNAT3 as partners in CSF amino acid homeostasis maintenance
por: Dolgodilina, Elena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2ko72dodcm4bvbr55t84ki1hgc